Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3.
Gobaru M, Ashida K, Yoshinobu S, Nagayama A, Kabashima M, Iwata S, Hasuzawa N, Tsuruta M, Wada N, Nakayama H, Motomura S, Tajiri Y, Nomura M. Gobaru M, et al. Among authors: tsuruta m. Am J Case Rep. 2019 Nov 20;20:1709-1714. doi: 10.12659/AJCR.918996. Am J Case Rep. 2019. PMID: 31745069 Free PMC article.
Pasireotide-induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist for treatment.
Shikata M, Ashida K, Goto Y, Nagayama A, Iwata S, Yano M, Hasuzawa N, Hara K, Mawatari K, Sakata K, Tsuruta M, Wada N, Nomura M. Shikata M, et al. Among authors: tsuruta m. Clin Case Rep. 2020 Aug 13;8(12):2613-2618. doi: 10.1002/ccr3.3230. eCollection 2020 Dec. Clin Case Rep. 2020. PMID: 33363790 Free PMC article.
Metreleptin Supplementation for Improving Lipid and Glycemic Profiles in Acquired Diabetes Lipodystrophy: A Case Report.
Nagayama A, Ashida K, Moritaka K, Hidaka M, Gobaru M, Tanaka S, Hasuzawa N, Akasu S, Goto Y, Motomura S, Hara K, Tsuruta M, Wada N, Nakayama H, Tajiri Y, Nomura M. Nagayama A, et al. Among authors: tsuruta m. J Endocr Soc. 2019 Sep 16;3(11):2179-2183. doi: 10.1210/js.2019-00251. eCollection 2019 Nov 1. J Endocr Soc. 2019. PMID: 31720553 Free PMC article.
Cross-sectional and Longitudinal Analyses of Factors Contributing to the Progressive Loss of the β-cell Function in Type 2 Diabetes.
Nakayama H, Kato T, Nakayama S, Kaku H, Muraishi K, Tokubuchi I, Hara K, Kato T, Wada N, Tsuruta M, Ohki T, Tanaka K, Mitsuzaki K, Tajiri Y, Yamada K. Nakayama H, et al. Among authors: tsuruta m. Intern Med. 2015;54(16):1971-6. doi: 10.2169/internalmedicine.54.4351. Epub 2015 Aug 15. Intern Med. 2015. PMID: 26278286 Free article.
Effects of a sodium glucose co-transporter 2 selective inhibitor, ipragliflozin, on the diurnal profile of plasma glucose in patients with type 2 diabetes: A study using continuous glucose monitoring.
Yamada K, Nakayama H, Yoshinobu S, Kawano S, Tsuruta M, Nohara M, Hasuo R, Akasu S, Tokubuchi I, Wada N, Hirao S, Iwata S, Kaku H, Tajiri Y. Yamada K, et al. Among authors: tsuruta m. J Diabetes Investig. 2015 Nov;6(6):699-707. doi: 10.1111/jdi.12370. Epub 2015 Jun 20. J Diabetes Investig. 2015. PMID: 26543545 Free PMC article.
228 results